Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Exelixis starts Phase lll trial of cabozantinib for DTC

Micrograph of a papillary thyroid carcinoma demonstrating diagnostic features. Credit: KGH.

Go Top